相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Peijie Wu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Tumor-Stromal Interactions in a Co-Culture Model of Human Pancreatic Adenocarcinoma Cells and Fibroblasts and Their Connection with Tumor Spread
Elena Prieto-Garcia et al.
BIOMEDICINES (2021)
Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway
Biqiang Zhu et al.
CANCER MEDICINE (2020)
Cancer-associated fibroblasts in cholangiocarcinoma
Javier Vaquero et al.
CURRENT OPINION IN GASTROENTEROLOGY (2020)
Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells
Sreeja Dattachoudhury et al.
ONCOLOGY (2020)
Tumor-neuroglia interaction promotes pancreatic cancer metastasis
Dan Su et al.
THERANOSTICS (2020)
Molecular Pathogenesis of Cholangiocarcinoma
Peter L. Labib et al.
BMC CANCER (2019)
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
Micol Eleonora Fiori et al.
MOLECULAR CANCER (2019)
Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells
Hyun Ju Hwang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Interleukin-17 Promotes Migration and Invasion of Human Cancer Cells Through Upregulation of MTA1 Expression
Na Guo et al.
FRONTIERS IN ONCOLOGY (2019)
TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
Doaa Tawfik et al.
FRONTIERS IN IMMUNOLOGY (2019)
SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating EMT
Jun-Dong Yang et al.
JOURNAL OF CHEMOTHERAPY (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib
Kenta Yokoi et al.
ONCOLOGY REPORTS (2018)
Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway
Xianhui Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11
Yao Wang et al.
PROSTATE (2018)
Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells
Shengling Fu et al.
ANTICANCER RESEARCH (2018)
Schwann cells: a new player in the tumor microenvironment
Yuri L. Bunimovich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer
Camila Cristina Guimaraes Nobre et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Interleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell lines
Shida Zhou et al.
PLOS ONE (2017)
The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments
Teizo Yoshimura
CYTOKINE (2017)
Cholangiocarcinoma
Michela Squadroni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis
Begum Erdogan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Nerve Dependence: From Regeneration to Cancer
Benoni Boilly et al.
CANCER CELL (2017)
Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts
Nils Heits et al.
BMC CANCER (2016)
Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways
Jiao Liu et al.
CANCER LETTERS (2016)
Schwann cells induce cancer cell dispersion and invasion
Sylvie Deborde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
ERK1/2 and AKT are vital factors in regulation of the migration of rat Schwann cells
Hao Yu et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2015)
Specific Marker Expression and Cell State of Schwann Cells during Culture In Vitro
Zhangyin Liu et al.
PLOS ONE (2015)
Focal Adhesion Kinase Knockdown in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis via Downregulating MCP-1/CCL2 Expression
Anjie Min et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2015)
Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth
Hiroaki Haga et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
M. Moehler et al.
EUROPEAN JOURNAL OF CANCER (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Investigation of Schwann Cells at Neoplastic Cell Sites Before the Onset of Cancer Invasion
Ihsan Ekin Demir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cancer-associated fibroblasts in digestive tumors
Lei Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
J. K. Lee et al.
BRITISH JOURNAL OF CANCER (2013)
Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: Involvement of the p21WAF1 expression
Eo-Jin Lee et al.
CELLULAR SIGNALLING (2013)
Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment
Hasaya Dokduang et al.
TUMOR BIOLOGY (2013)
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Shahid A. Khan et al.
JOURNAL OF HEPATOLOGY (2012)
Inflammation and cancer: macrophage migration inhibitory factor (MIF)-the potential missing link
H. Conroy et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
Masayuki Shimoda et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Hepatic Stellate Cells May Relate to Progression of Intrahepatic Cholangiocarcinoma
Hirohisa Okabe et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
CCL5 increases lung cancer migration via PI3K Akt and NF-kappa B pathways
Chun-Yin Huang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
A systems biology perspective on cholangiocellular carcinoma development: Focus on MAPK-signaling and the extracellular environment
Chunxia Wang et al.
JOURNAL OF HEPATOLOGY (2009)
Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma
Alexander Huether et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration
Manit Arya et al.
TUMOR BIOLOGY (2007)
From molecular biology to targeted therapies for hepatocellular carcinoma: The future is now
Roberta W. C. Pang et al.
ONCOLOGY (2007)
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-α via TNF receptor 2 and autocrine up-regulation of MCP-1
K Jöhrer et al.
CLINICAL CANCER RESEARCH (2004)
The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation
MC Harrisingh et al.
EMBO JOURNAL (2004)
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF)
RA Mitchell et al.
SEMINARS IN CANCER BIOLOGY (2000)
分享论文
